
Contract Research Organization (CROs) Services Market Global Industry Analysis and Forecast (2024-2032) by Service Type (Laboratory Services, Clinical Research Services, Early-phase Development Services, Regulatory Affairs, Consulting Services), Therapeutic Areas (Cardiovascular Diseases, Oncology, Diabetes, Respiratory Disorders, Central Nervous System Disorders, Others {Infectious Diseases, Ophthalmology, Gastroenterology & Hepatology, Metabolic Disorder}), End-User (Academic & Research Institutes, Medical Device Companies, Pharmaceutical & Biotechnological Companies), and Region
Contract Research Organization (CROs) Services Market Size Was Valued at USD 79.06 Billion in 2023, and is Projected to Reach USD 177.17 Billion by 2032, Growing at a CAGR of 9.38% From 2024-2032.
Contract Research Organizations (CROs) provide externalized research services to pharmaceutical, biotechnology, and medical device firms. They oversee clinical trials, perform lab services, and ensure regulatory adherence, simplifying the advancement of new drugs and medical devices.
Top Active Players
Medpace (U.S.), Laboratory Corporation of America Holdings (U.S.), IQVIA Inc (U.S.), Syneos Health (U.S.), KCR S.A. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Worldwide Clinical Trials (U.S.), Charles River Laboratories (U.S.), Microbiologics (U.S.), Parexel International (MA) Corporation (U.S.), Evotec SE (Germany), ICON plc (Ireland), PSI (Switzerland), Ergomed Group (UK), Novotech (Australia), Bioagile (India), WuXi Biologics (China), Tigermed (China), and Other Active Players.
Contract Research Organization (CROs) Services Market Segmented on the basis of Service Type, Therapeutic Areas, and End-User.
Global Contract Research Organization (CROs) Services Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 79.06 Bn. |
Forecast Period 2024-32 CAGR: |
9.38% |
Market Size in 2032: |
USD 177.17 Bn. |
Segments Covered: |
By Service Type |
|
|
By Therapeutic Areas |
|
||
By End-User |
|
||
By Region |
|
Global Contract Research Organization (CROs) Services Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 79.06 Bn. |
Forecast Period 2024-32 CAGR: |
9.38% |
Market Size in 2032: |
USD 177.17 Bn. |
Segments Covered: |
By Service Type |
|
|
By Therapeutic Areas |
|
||
By End-User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
The forecast period in the Contract Research Organization (CROs) Services Market research report is 2024-2032.
Medpace (U.S.), Laboratory Corporation of America Holdings (U.S.), IQVIA Inc (U.S.), Syneos Health (U.S.), KCR S.A. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Worldwide Clinical Trials (U.S.), Charles River Laboratories (U.S.), Microbiologics (U.S.), Parexel International (MA) Corporation (U.S.), Evotec SE (Germany), ICON plc (Ireland), PSI (Switzerland), Ergomed Group (UK), Novotech (Australia), Bioagile (India), WuXi Biologics (China), Tigermed (China), and Major Active Players.
The Contract Research Organization (CROs) Services Market is segmented into Service Type, Therapeutic Areas, End-User, and Region. By Service Type, the market is categorized into Laboratory Services, Clinical Research Services, Early-phase Development Services, Regulatory Affairs, and Consulting Services. By Therapeutic Areas, the market is categorized into Cardiovascular Diseases, Oncology, Diabetes, Respiratory Disorders, Central Nervous System Disorders, and Others. By Application, the market is categorized into Academic & Research Institutes, Medical Device Companies, and Pharmaceutical & Biotechnological Companies. By Region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Contract Research Organizations (CROs) provide externalized research services to pharmaceutical, biotechnology, and medical device firms. They oversee clinical trials, perform lab services, and ensure regulatory adherence, simplifying the advancement of new drugs and medical devices.
Contract Research Organization (CROs) Services Market Size Was Valued at USD 79.06 Billion in 2023, and is Projected to Reach USD 177.17 Billion by 2032, Growing at a CAGR of 9.38% From 2024-2032